Sort by:

select Language:

Guidance on chlamydia control in Europe

European Centre for Disease Prevention and Control, (2016)

This document updates the 2009 ECDC guidance on chlamydia control in Europe. It was developed by a technical expert group which conducted a critical review of the scientific evidence on the epidemiology of chlamydia and the effectiveness of screening programmes. The aim of this guidance is to support Member States to develop, implement or improve strategies for chlamydia control. This guidance describes the current evidence base behind the proposed options, highlights key gaps in knowledge, and suggests effective options for national chlamydia control strategies. It is directed primarily at policy advisors but should also be useful for programme managers and experts in sexual health.

Guidelines on the treatment of skin and oral HIV-associated conditions in children and adults

World Health Organization WHO, (2014)

Skin and mucosal conditions are extremely common in all children and adults in particular in HIV-infected adults and children and are one of the commonest daily management problems faced by health care workers caring for patients with HIV infection

HIVbook 2015-2016

Altfeld, M.; Barmeyer, A.; Behrens, G.; et al., (2016)

The hivbook is a medical textbook that follows the concept of being independent, easy to read, and freely available on the Internet.

Guide for HIV/AIDS Clinical Care

Susa Coffey,et al., Eds.: AECT; HRSA;US Dept.Health; et al., (2014)

Guideline on when to start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV

Elaine Abrams, Tsitsi Apollo, Janet Bhila et al., Eds.: World Health Organization WHO, (2015)

The new WHO guidelines recommend that people living with HIV be started on antiretrovirals (ARVs) as soon as possible after being diagnosed. Currently, many people living with the virus globally must wait until their CD4 counts fall to 500 to start treatment. According to the WHO, the move to early treatment –or what some have dubbed the “test and treat” model –is backed by the latest research.

2015 Pipeline Report HIV, Hepatitis C virus (HCV), and Tuberculosis (TB)

Polly Clayden, Simon Collins, Mike Frick, et al., Eds.: A. Benzacar; HIV i-BASE/TREATMENT ACTION GROUP, (2015)

Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development

92 hits